These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30419009)

  • 1. HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.
    Merindol N; El-Far M; Sylla M; Masroori N; Dufour C; Li JX; Cherry P; Plourde MB; Tremblay C; Berthoux L
    PLoS Pathog; 2018 Nov; 14(11):e1007398. PubMed ID: 30419009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
    Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
    AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
    Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
    J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
    AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
    Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
    Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
    Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
    J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
    Feeney ME; Tang Y; Pfafferott K; Roosevelt KA; Draenert R; Trocha A; Yu XG; Verrill C; Allen T; Moore C; Mallal S; Burchett S; McIntosh K; Pelton SI; St John MA; Hazra R; Klenerman P; Altfeld M; Walker BD; Goulder PJ
    J Immunol; 2005 Jun; 174(12):7524-30. PubMed ID: 15944251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
    Pohlmeyer CW; Buckheit RW; Siliciano RF; Blankson JN
    Retrovirology; 2013 Dec; 10():152. PubMed ID: 24330837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
    Feeney ME; Tang Y; Roosevelt KA; Leslie AJ; McIntosh K; Karthas N; Walker BD; Goulder PJ
    J Virol; 2004 Aug; 78(16):8927-30. PubMed ID: 15280502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
    J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
    Schneidewind A; Brockman MA; Sidney J; Wang YE; Chen H; Suscovich TJ; Li B; Adam RI; Allgaier RL; Mothé BR; Kuntzen T; Oniangue-Ndza C; Trocha A; Yu XG; Brander C; Sette A; Walker BD; Allen TM
    J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression.
    Brennan CA; Ibarrondo FJ; Sugar CA; Hausner MA; Shih R; Ng HL; Detels R; Margolick JB; Rinaldo CR; Phair J; Jacobson LP; Yang OO; Jamieson BD
    J Virol; 2012 Oct; 86(19):10505-16. PubMed ID: 22811521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.